Valuation: LeMaitre Vascular, Inc.

Market Cap 1.68B 1.53B 1.41B 1.29B 2.41B 156B 2.54B 17.2B 6.84B 85.19B 6.32B 6.19B 267B P/E 2026 *
26.4x
P/E 2027 * 23.4x
Enterprise Value 1.44B 1.31B 1.21B 1.1B 2.07B 134B 2.17B 14.75B 5.86B 73.02B 5.42B 5.3B 229B EV / Sales 2026 *
5.23x
EV / Sales 2027 * 4.56x
Free-Float
87.27%
Yield 2026 *
1.36%
Yield 2027 * 1.52%
1 day-1.67%
1 week-5.98%
Current month-9.06%
1 month-11.74%
3 months-10.58%
6 months-27.43%
Current year-9.24%
1 week 73.44
Extreme 73.44
78.36
1 month 73.44
Extreme 73.44
89.23
Current year 73.44
Extreme 73.44
118.01
1 year 73.44
Extreme 73.44
118.01
3 years 51.7
Extreme 51.6972
118.01
5 years 38.32
Extreme 38.32
118.01
10 years 18.76
Extreme 18.76
118.01
Manager TitleAgeSince
Chief Executive Officer 61 1992-05-31
Director of Finance/CFO 51 2025-03-09
Director of Finance/CFO 62 1999-12-31
Director TitleAgeSince
Director/Board Member 68 2002-12-31
Chairman 61 2003-12-31
Director/Board Member 61 2016-10-23
Date Insider Type Main position Quantity % Market Cap. Importance
9/3/26 Free

Chairperson

24 0.0001%
9/3/26 Free

Director

6 0.0000%
9/3/26 Free

Chief Operating Officer

14 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-1.67%-5.98%-12.83%+36.92% 1.69B
-2.79%-4.38%+16.90%+42.75% 248B
-3.16%-5.43%-0.82%+4.42% 155B
-2.01%-10.04%-27.74%+28.17% 138B
-2.35%-5.32%-56.54%-22.92% 60.85B
-1.95%-4.95%+21.12%+51.59% 58.56B
-1.96%-2.25%+4.04%-14.08% 52.46B
-2.83%-2.06%+17.45%+49.48% 48.04B
-3.51%-4.30%+16.33%+68.80% 43.29B
+1.26%-11.71%-1.58%+48.97% 43.1B
Average -2.10%-4.39%-2.37%+29.41% 85B
Weighted average by Cap. -2.42%-3.87%-0.36%+27.79%

Financials

2026 *2027 *
Net sales 276M 251M 232M 211M 395M 25.56B 415M 2.82B 1.12B 13.96B 1.04B 1.01B 43.82B 303M 276M 255M 232M 435M 28.1B 457M 3.1B 1.23B 15.35B 1.14B 1.11B 48.17B
Net income 64.56M 58.8M 54.18M 49.28M 92.46M 5.98B 97.17M 659M 262M 3.27B 242M 237M 10.25B 73.42M 66.87M 61.62M 56.05M 105M 6.8B 111M 750M 298M 3.71B 275M 270M 11.65B
Net Debt -240M -219M -202M -184M -344M -22.27B -362M -2.46B -976M -12.16B -902M -883M -38.18B -300M -274M -252M -229M -430M -27.82B -452M -3.07B -1.22B -15.19B -1.13B -1.1B -47.68B
Projected Income Statement - Annual - LeMaitre Vascular, Inc.
Logo LeMaitre Vascular, Inc.
LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. It develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser degree, other specialties, such as cardiac surgeons, general surgeons, and neurosurgeons. Its portfolio of product lines is used to treat vascular disease, which are used in open vascular surgery and dialysis access. It offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy and occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. Its principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. Its product offerings are sold globally in the United States, Europe, Canada and Asia Pacific.
Employees
651
Date Price Change Volume
26-11-20 $73.61 -1.67% 313,554
26-11-19 $74.86 -0.95% 250,301
26-11-18 $75.58 -0.68% 222,736
26-11-17 $76.10 -1.18% 190,508
26-11-16 $77.01 -1.63% 294,611
Trader
Investor
Global
Quality
ESG MSCI
CCC
MarketScreener Ratings - LeMaitre Vascular, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
73.61USD
Average target price
99.29USD
Spread / Average Target
+34.88%
  1. Stock Market
  2. Stocks
  3. LMAT Stock